Bolt Biotherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bolt Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Bolt Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $16.8M, a 15.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $16.8M -$3.12M -15.7% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $17.6M -$3.06M -14.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $18.3M -$3.01M -14.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $19.1M -$2.95M -13.4% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $19.9M -$2.9M -12.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $20.6M -$1.99M -8.78% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $21.4M -$1.92M -8.25% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $22.1M -$2.37M -9.71% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $22.8M -$2.44M -9.67% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $22.6M -$3.37M -13% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $23.3M +$11.8M +103% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $24.4M +$12.2M +99.3% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $25.2M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $26M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $11.5M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $12.3M Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.